141 related articles for article (PubMed ID: 31665931)
1. Neutrophil-lymphocyte ratio and nutritional status are clinically useful in predicting prognosis in colorectal cancer patients.
Silva TH; Schilithz AOC; Peres WAF; Murad LB
Nutr Cancer; 2020; 72(8):1345-1354. PubMed ID: 31665931
[No Abstract] [Full Text] [Related]
2. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis.
Li MX; Liu XM; Zhang XF; Zhang JF; Wang WL; Zhu Y; Dong J; Cheng JW; Liu ZW; Ma L; Lv Y
Int J Cancer; 2014 May; 134(10):2403-13. PubMed ID: 24122750
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer.
Kim JH; Lee JY; Kim HK; Lee JW; Jung SG; Jung K; Kim SE; Moon W; Park MI; Park SJ
World J Gastroenterol; 2017 Jan; 23(3):505-515. PubMed ID: 28210087
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.
Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y
Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Dynamic Neutrophil-lymphocyte Ratio Changes in Patients With Colorectal Cancer.
Ashizawa N; Furuya S; Katsutoshi S; Sudo M; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Kawaida H; Inoue S; Kono H; Ichikawa D
Anticancer Res; 2020 Apr; 40(4):2311-2317. PubMed ID: 32234931
[TBL] [Abstract][Full Text] [Related]
9. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
[TBL] [Abstract][Full Text] [Related]
10. Prediction of survival of preoperative colorectal patients: A new tool to assess the interaction of nutritional status and inflammation.
Silva TH; Sillos André JC; Orlando Correa Schilithz A; Borges Murad L; Arantes Ferreira Peres W
Clin Nutr ESPEN; 2023 Aug; 56():230-236. PubMed ID: 37344078
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment Inflammatory Indexes as Prognostic Predictors for Survival in Colorectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.
Yang J; Xu H; Guo X; Zhang J; Ye X; Yang Y; Ma X
Sci Rep; 2018 Feb; 8(1):3044. PubMed ID: 29445100
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer.
Mercier J; Voutsadakis IA
J Gastrointest Cancer; 2019 Sep; 50(3):493-506. PubMed ID: 29704170
[TBL] [Abstract][Full Text] [Related]
13. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer.
Chen ZY; Raghav K; Lieu CH; Jiang ZQ; Eng C; Vauthey JN; Chang GJ; Qiao W; Morris J; Hong D; Hoff P; Tran H; Menter DG; Heymach J; Overman M; Kopetz S
Br J Cancer; 2015 Mar; 112(6):1088-97. PubMed ID: 25688736
[TBL] [Abstract][Full Text] [Related]
14. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
15. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
16. [Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer].
Jiang H; Wang H; Li A; Tang E; Chen Y; Wang A; Deng X; Lin M
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):550-554. PubMed ID: 28534334
[TBL] [Abstract][Full Text] [Related]
17. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
18. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery: A meta-analysis.
Li H; Zhao Y; Zheng F
Medicine (Baltimore); 2019 Jan; 98(3):e14126. PubMed ID: 30653142
[TBL] [Abstract][Full Text] [Related]
20. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.
Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X
BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
